Phi Pharma SA is developing a new class of anti-cancer drugs: Peptide Drug Conjugates (PDCs) effective in multiple human cancers using an innovative mechanism of cell entry: novel CSPG4 targeting bio-pharmaceuticals.
Phi Pharma SA
Verified listing
-
Founded2012
-
Employees in Switzerland1-9
- Website
- Get directions
- Bookmark
- Share
- Report
- prev
- next